Patent details
EP2964202 Title: ORAL FORMULATIONS OF DEFERASIROX
Basic Information
- Publication number:
- EP2964202
- PCT Application Number:
- IB2014059494
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP147106546
- PCT Publication Number:
- WO2014136079
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- ORAL FORMULATIONS OF DEFERASIROX
- French Title of Invention:
- FORMULATIONS ORALES DE DÉFÉRASIROX
- German Title of Invention:
- ORALE FORMULIERUNGEN VON DEFERASIROX
- SPC Number:
Dates
- Filing date:
- 06/03/2014
- Grant date:
- 31/10/2018
- EP Publication Date:
- 13/01/2016
- PCT Publication Date:
- 12/09/2014
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 31/10/2018
- EP B1 Publication Date:
- 31/10/2018
- EP B2 Publication Date:
- 31/05/2023
- EP B3 Publication Date:
- Lapsed date:
- 06/03/2024
- Expiration date:
- 06/03/2034
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 24/05/2023
- Name:
- Novartis AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
Inventor
1
- Name:
- GHOSH, Indrajit
- Address:
- United States (US)
2
- Name:
- ZHANG, Jia-Ai
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201361774893 P
- Priority Date:
- 08/03/2013
- Priority Country:
- United States (US)
2
- Priority Number:
- 201361824435 P
- Priority Date:
- 17/05/2013
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 9/20; A61K 9/28; A61K 9/50; A61K 31/4196; A61P 39/04;
Publication
European Patent Bulletin
1
- Issue number:
- 201844
- Publication date:
- 31/10/2018
- Description:
- Grant (B1)
2
- Issue number:
- 201936
- Publication date:
- 04/09/2019
- Description:
- Opposition procedure started
3
- Issue number:
- 201935
- Publication date:
- 28/08/2019
- Description:
- Opposition procedure started
4
- Issue number:
- 202322
- Publication date:
- 31/05/2023
- Description:
- Patent maintained (B2 publication)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- 27/02/2023
- Last Annual Fee Paid Number:
- 10
- Last Annual Fee Paid Amount:
- 131 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM
| Filing date | Document type | Number of pages |
|---|